Detalhe da pesquisa
1.
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer.
Prostate
; 84(1): 100-110, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37796107
2.
ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype.
Br J Cancer
; 129(11): 1818-1828, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37798372
3.
Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Prostate
; 78(16): 1262-1282, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30073676
4.
LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics.
Prostate
; 77(6): 654-671, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28156002
5.
Conversion of Prostate Adenocarcinoma to Small Cell Carcinoma-Like by Reprogramming.
J Cell Physiol
; 231(9): 2040-7, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26773436
6.
Addition of PSMA ADC to enzalutamide therapy significantly improves survival in in vivo model of castration resistant prostate cancer.
Prostate
; 76(3): 325-34, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26585210
7.
Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer xenografts.
Prostate
; 75(3): 303-13, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25327986
8.
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis.
Mol Oncol
; 18(3): 726-742, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225213
9.
UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas.
Cell Rep Med
; 5(2): 101381, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244540
10.
Establishment and serial passage of cell cultures derived from LuCaP xenografts.
Prostate
; 73(12): 1251-62, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23740600
11.
Inhibition of CCL2 signaling in combination with docetaxel treatment has profound inhibitory effects on prostate cancer growth in bone.
Int J Mol Sci
; 14(5): 10483-96, 2013 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23698775
12.
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients.
medRxiv
; 2023 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36865297
13.
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers.
Cancer Res Commun
; 3(11): 2358-2374, 2023 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823778
14.
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes.
Cancer Discov
; 13(3): 632-653, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399432
15.
Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.
Am J Pathol
; 179(1): 400-10, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21703419
16.
Sequencing SARS-CoV-2 from antigen tests.
PLoS One
; 17(2): e0263794, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134077
17.
Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome.
JCI Insight
; 7(10)2022 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603787
18.
Caring for the Animal Caregiver-Occupational Health, Human-Animal Bond and Compassion Fatigue.
Front Vet Sci
; 8: 731003, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34820435
19.
Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer.
Cancer Res
; 81(6): 1583-1594, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33483372
20.
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature.
PLoS One
; 16(1): e0245602, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471819